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Abstract
Objective: The aim of the current study was to investigate which is the most suitable classification for colorectal cancer, log
odds of positive lymph nodes (LODDS) classification or the classifications based on the number of positive lymph nodes
(pN) and positive lymph node ratio(LNR) in a Chinese single institutional population.
Design: Clinicopathologic and prognostic data of 1297 patients with colorectal cancer were retrospectively studied. The
log-rank statistics, Cox’s proportional hazards model, the Nagelkerke R
2 index and a Harrell’s C statistic were used.
Results: Univariate and three-step multivariate analyses identified that LNR was a significant prognostic factor and LNR
classification was superior to both the pN and LODDS classifications. Moreover, the results of the Nagelkerke R
2 index
(0.130) and a Harrell’s C statistic (0.707) of LNR showed that LNR and LODDS classifications were similar and LNR was a
little better than the other two classifications. Furthermore, for patients in each LNR classification, prognosis was
homologous between those in different pN or LODDS classifications. However, for patients in pN1a, pN1b, LODDS2
and LODDS3 classifications, significant differences in survival were observed among patients in different LNR
classifications.
Conclusions: For patients with colorectal cancer, the LNR classification is more suitable than pN and LODDS classifications
for prognostic assessment in a Chinese single institutional population.
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Introduction
Colorectal cancer is the third most common cancer for both
males and females, as well as the second leading cause of cancer-
related death in the western world [1]. In China, with
improvements in living standards and changes in diet, the
incidence of colorectal cancer is gradually increasing [2]. Recently,
the incidence of colorectal cancer and its cancer-related mortality
have become the fourth highest of all cancers in China [3]. As is
well known, lymph node (LN) metastasis is one of the most
important prognostic factors in patients with colorectal cancers [4–
10].
In the 7
th edition of the UICC/AJCC TNM staging system,
based on the number of tumor-infiltrated lymph nodes, the pN
category was stratified into pN1 (1–3 positive LNs) and pN2 ($4
positive LNs) [4]. The lymph node ratio (LNR), namely, the ratio
of positive LNs divided by the total number of retrieved LNs,
reflects the probability of positive LNs in the retrieved LNs [5].
Recently, the LNR has been reported to represent a powerful
independent prognostic value in colorectal cancer [5–10].
Interestingly, another novel prognostic indicator, log odds of
positive lymph nodes (LODDS), has been proposed in recent
years. LODDS is defined as the log of the quotient of the number
of positive lymph nodes and the number of negative lymph nodes
and has been introduced as a new prognostic factor in breast
cancer research [11,12]. Moreover, Wang et al. studied 24,477
patients with stage III colon cancer who were registered in the
Surveillance Epidemiology and End Results (SEER) database and
revealed that LODDS was a better prognostic factor than LNR
[13]. However, to date, no study comparing the prognostic value
among pN, LNR and LODDS classifications for colorectal cancer
in Chinese patients has been reported.
In light of these considerations, the aim of the current study was
to investigate which is the most suitable classification among pN,
LNR and LODDS classifications in prognostic assessment for
colorectal cancer patients with R0 resection in a Chinese single
institutional population.
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Patients
From our prospective database, clinical information on all
patients with colorectal cancer that underwent surgery at the
Department of Surgical Oncology at the First Hospital of China
Medical University from April 1994 to December 2007 were
retrospectively collected, reviewed, and analyzed. No previous
local or systemic treatment had been conducted for these patients
before operation. Specimens which were fixed in formalin and
stained with hematoxylin-eosin (H&E) were used for histopatho-
logical evaluation. This study consisted of stage I–III colorecal
cancers. Patients (i) who died in the postoperative period (within
30 days), (ii) with multiple adenocarcinomas of the colon and
rectum, (iii) with synchronous or metachronous tumors, (iv) who
underwent neoadjuvant treatment due to presumed treatment-
related changes in the TNM classification, (v) with incomplete
pathological data entries, (vi) who were lost to follow-up, (vii) with
tumor deposits, and (viii) distant metastasis were excluded in this
study. Follow-up was completed for the entire study population
until November 2008.
Of the remaining 1297 patients, the median and mean follow-
up periods were 47 months and 56636 months (range: 1–167
months), respectively. The following data were obtained: age,
gender, date of surgery, date of death (if applicable), cause of death
(if applicable), date of follow-up, location of the primary tumor,
tumor size, histologic grade, venous invasion, lymphovascular
invasion, depth of invasion, number of retrieved lymph nodes and
number of metastatic lymph nodes. Tumors originating from the
cecum to the sigmoid colon were defined as colon cancers and
tumors located in the rectum or rectosigmoid junction were
considered as rectal cancers [14].
Ethics statement
The study was approved by the Research Ethics Committee of
China Medical University, China. Written informed consents were
obtained from all patients before participating in the study.
Classification methods and Statistical Analysis
According to the 7
th edition of the UICC/AJCC TNM staging
system, based on the number of tumor-infiltrated lymph nodes, the
pN category was stratified into pN0: no positive LNs; pN1a: 1
positive LN; pN1b: 2–3 positive LNs; pN2a: 4–6 positive LNs; and
pN2b: $7 positive LNs [4]. LNR was defined as the ratio of
positive LNs divided by the total number of retrieved LNs,
reflecting the probability of positive LNs in the retrieved LNs,
which does not significantly depend on the number of LNs
harvested [5]. LODDS was estimated by: log
(pnodz0:5)
(tnod{pnodz0:5)
,
where the pnod is the number of positive lymph nodes and tnod is
the total number of lymph nodes retrieved, and 0.5 is added to
both numerator and denomination to avoid singularity [13].
To obtain optimal cut-off values for LNRs and LODDS
classifications, running log-rank statistics was applied [15].
Cancer-specific survival was analyzed by Kaplan-Meier survival
curves and comparisons were made by the log-rank test.
Multivariate analysis was performed using backward stepwise
Cox’s proportional hazards model [16]. Three-step multivariate
analysis was performed to investigate which N staging system had
more potential to predict patient outcomes. The p-spline (Fitting
Spline Models) function is used to fit a general spline term within
the Cox model [17]. The Nagelkerke R
2 index (R
2
N) was used to
score the different Cox models [18]. R
2 represents the proportion
of variation explained by covariates in regression models [18,19].
R
2
N divides R
2 by its maximum attainable value to scale it to
Table 1. Univariate analysis of the prognostic factors for
patients with colorectal cancer.
N
a 5-YSR
b(%) P value*
Sex 0.014
Male 715 74
Female 582 81
Age 0.003
#60 594 81
.60 703 74
Tumor location 0.931
Rectum 711 76
Colon 586 78
Tumor size 0.947
#5 782 77
.5 515 77
Histologic grade ,0.001
Well 646 82
Moderate 564 72
Poor 87 63
Venous invasion 0.701
Positive 7 67
Negative 1290 77
Lymphovascular
invasion
,0.001
Positive 60 52
Negative 1237 78
pT stage ,0.001
T1 36 92
T2 316 88
T3 795 76
T4 150 58
pN stage ,0.001
N0 935 86
N1a 138 61
N1b 121 56
N2a 65 37
N2b 38 30
LNR ,0.001
LNR0 935 86
LNR1 99 68
LNR2 164 59
LNR3 57 38
LNR4 42 12
LODDS ,0.001
LODDS1 774 87
LODDS2 223 75
LODDS3 201 66
LODDS4 61 36
LODDS5 38 13
N
a: Number of patients.
5-YSR
b: 5-year accumulative survival rate.
*: P values were made by log-rank test.
doi:10.1371/journal.pone.0028937.t001
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2
N is close to 1 for a perfectly predictive
model, and close to 0 for a model that does not discriminate
between short and long survival times. After each regression, a
Harrell’s C statistic was run to test the predictive capacity and fit of
the model, respectively. A model with perfect predictive capacity
(sensitivity and specificity of 100%) would have a Harrell’s C
statistic of 1.00 and the highest Harrell’s C statistic was chosen as
the best model [20].
All the statistical analyses and graphics were performed with the
SPSS 17.0 statistical package (SPSS, Chicago, IL), Splus 8.0
(Insightful Corporation, Seattle, WA, USA) and STATA MP
ver.10 (StataCorp LP, College Station, TX) statistical software.
For all analysis, P,0.05 was considered significant.
Results
The number of lymph nodes examined in each specimen
ranged from 1 to 107 with a mean of 13 and a median of 11.
According to the 7
th edition of the UICC/AJCC TNM staging
system, based on the number of tumor-infiltrated lymph nodes, the
patients with different pN categories were divided into pN0:
935(72%); pN1a: 138(11%); pN1b: 121(9%); pN2a: 65(5%); and
Figure 1. Survival curves of colorectal cancer patients according to three classifications (pN, LNR, LODDS) are depicted.
doi:10.1371/journal.pone.0028937.g001
Table 2. Univariate and Three-step Multivariate Analysis (Cox Proportional Hazard Model) of Prognostic Factors.
Univariate Analysis Multivariate Analysis 1 Multivariate Analysis 2 Multivariate Analysis 3
RR
a 95% CI
b P RR 95% CI P RR 95% CI P RR 95% CI P
Sex, female vs male 0.730 0.567–0.940 0.015 0.714 0.555–0.920 0.009 0.762 0.592–0.982 0.035 0.762 0.592–0.982 0.035
Age* 1.016 1.005–1.027 0.004 1.023 1.012–1.034 ,0.001 1.019 1.008–1.030 0.001 1.019 1.008–1.030 0.001
Tumor location,
colon vs rectum
0.989 0.773–1.266 0.931
Tumor size* 1.009 0.955–1.067 0.739
Histologic grade, well
vs moderate vs poor
1.521 1.264–1.829 ,0.001 1.229 1.012–1.493 0.037
Venous invasion,
positive vs negative
1.312 0.326–5.277 0.702
Lymphovascular invasion,
positive vs negative
2.733 1.795–4.162 ,0.001 2.193 1.409–3.414 0.001 2.603 1.691–4.008 ,0.001 2.603 1.691–4.008 ,0.001
pT stage, T1 vs
T2 vs T3 vs T4
2.047 1.695–2.473 ,0.001 1.764 1.446–2.152 ,0.001 1.735 1.428–2.107 ,0.001 1.735 1.428–2.107 ,0.001
pN stage, N0 vs N1a
vs N1b vs N2a vs N2b
1.796 1.646–1.961 ,0.001 1.676 1.531–1.835 ,0.001
LNR, LNR0 vs LNR1 vs
LNR2 vs LNR3 vs LNR4
1.915 1.759–2.086 ,0.001 1.793 1.644–1.955 ,0.001 1.793 1.644–1.955 ,0.001
LODDS, LODDS1 vs
LODDS2 vs LODDS3 vs
LODDS4 vs LODDS5
1.939 1.765–2.130 ,0.001
RR
a: relative risk.
CI
b: confidence interval.
*: continuous variable.
doi:10.1371/journal.pone.0028937.t002
Most Suitable Classification for Colorectal Cancer
PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28937pN2b: 38(3%). The survival differences were statistically significant
(P,0.001; Table 1 and Fig. 1A).
Using running log-rank statistics, we calculated the best cut-off
LNR values and proposed a novel LNR category: LNR0: 0%;
LNR1: 0%,LNR#11%; LNR2: 11%,LNR#36%; LNR3:
36%,LNR#66% and LNR4.66%. Patients were categorized
into five groups according to the LNR category: 935(72%) were as
LNR0; 99(8%) were as LNR1; 164(13%) were as LNR2; 57(4%)
were as LNR3 and 42(3%) were as LNR4. The 5-year cancer-
specific survival rate decreased significantly with increasing LNRs:
LNR0=86% survival rate; LNR1=68% survival rate;
LNR2=59% survival rate; LNR3=38% survival rate; and
LNR4=12% survival rate (P,0.001; Table 1 and Fig. 1B).
As shown in Table 1 and Fig. 1C, based on the LODDS
classification, five groups were identified by running log-rank
statistics: LODDS1#22.510; 22.510,LODDS2#21.680;
21.680,LODDS3#20.510; 20.510,LODDS4#0.730; and
LODDS5.0.730. The 5-year cancer-specific survival rates were
87%, 75%, 66%, 36% and 13%, respectively. The survival rate
decreased significantly with increasing LODDS (P,0.001).
Moreover, in univariate analysis, sex, age, histologic grade,
lymphovascular invasion, and pT stage were also significantly
correlated with prognosis (Table 1).
Then, we used univariate and three-step multivariate analysis
(Cox Proportional Hazard Model) to find the most significant
prognostic factors (Table 2). In univariate analysis, sex, age,
histologic grade, lymphovascular invasion, pT stage, pN stage,
LNR classification and LODDS classification were significant
prognostic factors. Next, the step 1 multivariate analysis showed,
pN classification, sex, age, histologic grade, lymphovascular
invasion and pT classification were confirmed to be independent
prognostic factors. After that, LNR classification was added to
construct the model in the step 2 multivariate analysis, and LNR
classification became significant, while pN classification and
histologic grade dropped out of the model. Moreover, when all
3 N classifications were included in the step 3 multivariate analysis,
LODDS and pN classifications were substituted by the LNR
classification (Table 2).
Furthermore, in fitting spline models, the number of nodes
examined and pN exhibited marked nonlinearity and widely
diverging confidence intervals (Fig. 2A and 2B). The linearity
improved for LNR and LODDS classifications, which also showed
more homogeneously distributed confidence intervals (Fig. 2C and
2D).
Based on R
2
N, the results showed a comparison between
proportional hazards models that included pN(R
2
N=0.100),
Figure 2. In fitting spline models, colorectal cancer mortality as a function of different classifications. Dotted lines indicate the 95%
confidence interval.
doi:10.1371/journal.pone.0028937.g002
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2
N=0.130) and LODDS(R
2
N=0.119). The best predictive
covariate model was LNR, obviously. Then, we used Harrell’s C
statistic to test the predictive capacity and fit of the model. The
Harrell’s C value and 95% CI of LNR (0.707, 0.675–0.739) and
LODDS (0.708, 0.674–0.741) were similar and better than that of
pN classification (0.698, 0.666–0.730). Comparing the predictive
power of survival models with pN, LNR was significant
(P=0.002), but LODDS was not (P=0.348). When we compared
the predictive power between LNR and LODDS, there was no
significant difference (P=0.962).
Table 3 listed cancer-specific survival rates on the basis of pN
and LODDS classification according to the LNR staging system.
As shown, for patients in each LNR classification, prognosis was
highly homologous between those in different pN or LODDS
classifications. However, for patients in pN1a, pN1b, LODDS2
and LODDS3 classifications, significant differences in survival
could always be observed among patients in different LNR
classifications.
To explain why the LODDS classification was similar to LNR,
we plotted scatter plots of the relationship among the three
classifications. As shown in Fig. 3A, every pN classification can be
divided into different LNR classifications. However, Fig. 3B
showed that the patient distribution of LODDS classification was
similar to the LNR classification and the value of LODDS
increased with LNR increasing, indicating there was a close
correlation between LODDS and LNR (except LNR=0). When
the LNR was 0, the value of LODDS was heterogeneous.
However, Table 3 showed, for patients in the LNR0, prognosis
was highly homologous between those in LODDS1, LODDS2
and LODDS3 classifications.
Discussion
Although UICC/AJCC TNM classification was revised signif-
icantly from the 5
th edition to the 7
th edition, especially in regard
to the pN categories [4,21,22], the pN categories still have some
deficiencies. The primary flaw of the number-based UICC/AJCC
pN classification is that the accuracy of the predicting prognosis
was significantly influenced by the total number of nodes retrieved.
According to the guidelines for colorectal cancer from the AJCC/
UICC, only when the number of LNs that were retrieved and
examined was 12 or more, it could be regarded as an adequate
lymphadenectomy for accurate staging [4]. However, cases with
insufficiently retrieved and examined LNs are not unusual in
clinical practice. This led to the development and adoption of new
prognostic indices that incorporate all the lymph node information
in a single identifiable parameter. Among the indices, the
important and promising classifications are the LNR and LODDS
classifications [8,13].
LNR has been identified as a significant prognostic value in
breast cancer [23], pancreatic cancer [24], gastric cancer [25].
Furthermore, an increasing number of studies have demonstrated
that the LNR classification is superior to the pN classification in
colorectal cancer [5–10,26]. LODDS, a novel indicator of
predicting the status of lymph nodes, provides a new chance to
improve the accuracy of N classification for prognostic assessment.
But research on LODDS has mainly focused on breast and gastric
cancer [11,12,27]. Only the study of Wang et al. revealed that
LODDS was a better prognostic factor than LNR classification
[13].
In our study, pN, LNR and LODDS classifications were all
identified as significant prognostic factors in univariate analysis.
To investigate whether one N classification was superior to the
others, multistep multivariate analysis has often been used [27,28].
For example, to prove the LNR classification was superior to the
pN classification, we performed a three-step multivariate analysis.
In the step 1 multivariate analysis, pN classification was one of the
independent prognostic factors, whereas in the step 2 multivariate
analysis, pN classification was substituted by the LNR classifica-
Table 3. Cancer-specific survival rates on the basis of pN and LODDS classification according to the LNR staging system.
LNR0 LNR1 LNR2 LNR3 LNR4 P
a
N
d 5-YSR
e (%) N
d 5-YSR
e (%) N
d 5-YSR
e (%) N
d 5-YSR
e (%) N
d 5-YSR
e (%)
pN classification
pN0 935 86 0 0 0 0 -
pN1a 0 84 66 46 61 5 20 3 0 ,0.001
pN1b 0 15 82 83 61 13 57 10 0 ,0.001
p N 2 a 0 0 2 8 5 32 6 2 91 1 2 50 . 1 5 0
pN2b 0 0 7 67 13 56 18 13 0.093
P
b - 0.409 0.972 0.719 0.115
LODDS classification
LODDS1 745 87 29 79 0.412
LODDS2 137 81 70 63 16 68 0.017
LODDS3 53 80 148 58 0.002
LODDS4 57 38 4 0 0.362
LODDS5 38 13 -
P
c 0.346 0.153 0.471 - 0.884
P
a: Comparison of survival rates between different LNR groups.
P
b: Comparison of survival rates between different pN groups.
P
c: Comparison of survival rates between different LODDS groups.
N
d: Number of patients.
5-YSR
e: 5-year accumulative survival rate.
doi:10.1371/journal.pone.0028937.t003
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including all the 3 N classifications (pN, LNR and LODDS). The
results indicated that the LNR classification was superior to both
the pN classification and the LODDS classification. On the other
hand, the results of the Nagelkerke R
2 index and a Harrell’s C
statistic showed that LNR and LODDS classification were similar
and LNR was a little better than the other two classifications.
LODDS classification divided the patients with negative lymph
node into three groups: LODDS1, LODDS2 and LODDS3. In
contrast,patients with negative lymph node were staged only as
pN0 or LNR0 in pN or LNR classifications. Unfortunately, no
significant survival difference was found among the patients in
three LODDS classifications in the present study. Therefore, the
prognostic effect of LODDS classification for negative lymph
nodes colorectal cancer patients need further investigation in
larger samples. Furthermore, our results further confirmed the
superiority of the LNR classification: for patients in each LNR
classification, prognosis was highly homologous among those in
different pN or LODDS classifications. However, for patients in
pN1a, pN1b, LODDS2 and LODDS3 classifications, significant
differences in survival could always be observed among patients in
different LNR classifications. Thus, we think the LNR classifica-
tion is superior to the pN and LODDS classifications and it can
contribute to accuracy in prognostic assessment.
To date, although a number of studies have shown that LNR
classification was superior to the pN classification, no study
comparing the prognostic value among pN, LNR and LODDS
classifications for colorectal cancer in Chinese patients has been
reported. In our study, we first demonstrated that the LNR
classification was superior to the pN and LODDS classifications in
1297 Chinese patients with colorectal cancer. However, Wang et
al. studied 24,477 patients with stage III colon cancer that were
registered in the SEER database and revealed that LODDS was a
better prognostic factor than LNR. It is possible that different cut
off points acquired from different statistical methods for subclas-
sification, different populations, different environments and
different diet habits contribute to these different results.
In clinical practice, when the LNs that were retrieved and
examined were insufficient, a so-called ‘‘stage migration’’ phe-
nomenon [25] appeared due to inappropriate staging in the pN
classification and the prognosis of the patient was underestimated.
On the other hand, as the LNR classification is easier to calculate
than the LODDS classification, LNR is recommended to be used
in clinical practice.
Our study has some limitations. Our conclusion results from a
Chinese single institutional study in 1297 patients with colorectal
cancer. We used running log-rank statistics to calculate our cut-off
values which were different from previous studies. Whether our
results and cut-off values for LNR and LODDS can be applied to
other institutions remains to be demonstrated. We look forward to
performing larger sample studies and international multicentric
research on LNR and LODDS classifications in colorectal cancer
in the near future.
In conclusion, for patients with colorectal cancer, the LNR
classification is more suitable than pN and LODDS classifications
for prognostic assessment. Although the best and most clinically
meaningful cut-off value for LNR classification has yet to be
determined, we still believe that the LNR classification is the most
reliable N classification to date and should be recognized in China
in the future.
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